A Cross-Study Transcriptional Analysis of Parkinson's Disease
暂无分享,去创建一个
Christine A. Wells | Peter A. Silburn | Alan Mackay-Sim | Alistair M. Chalk | George D. Mellick | C. Wells | A. Chalk | P. Silburn | A. Mackay-Sim | N. Matigian | G. Sutherland | G. Mellick | Nicholas A. Matigian | Greg T. Sutherland | Matthew J. Anderson | Matthew Anderson
[1] A. Graybiel,et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.
[2] C. Hawkes,et al. Olfaction in neurodegenerative disorder. , 2006, Advances in oto-rhino-laryngology.
[3] L. Moran,et al. Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s disease , 2006, Neurogenetics.
[4] P. Mcgeer,et al. Glial reactions in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[5] Alan Mackay-Sim,et al. Fibroblast and Lymphoblast Gene Expression Profiles in Schizophrenia: Are Non-Neural Cells Informative? , 2008, PloS one.
[6] Abraham Weizman,et al. Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson’s disease , 2001, Neuroscience Letters.
[7] S. Gilman,et al. Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.
[8] T. Moos,et al. The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease , 1999, Neuroscience.
[9] Ling Lin,et al. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. , 2005, Human molecular genetics.
[10] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[11] M. Graeber,et al. Controversies over the staging of α-synuclein pathology in Parkinson’s disease , 2008, Acta Neuropathologica.
[12] H. Federoff,et al. Altered Gene Expression Profiles Reveal Similarities and Differences Between Parkinson Disease and Model Systems , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[13] A. Cavallini,et al. Autonomic dysfunction in Parkinson's disease , 2003, Neurological Sciences.
[14] D. Mash,et al. Multiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson's disease. , 2006, Gene expression.
[15] M. Graeber,et al. Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration , 2006, Acta Neuropathologica.
[16] E. Hirsch,et al. Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian , 2005, Journal of Neural Transmission.
[17] D. Maraganore,et al. A Genomic Pathway Approach to a Complex Disease: Axon Guidance and Parkinson Disease , 2007, PLoS genetics.
[18] Helen E. Parkinson,et al. ArrayExpress—a public database of microarray experiments and gene expression profiles , 2006, Nucleic Acids Res..
[19] C. Kruse,et al. Analysis of Gene Expression in Parkinson's Disease: Possible Involvement of Neurotrophic Support and Axon Guidance in Dopaminergic Cell Death , 2009, Brain pathology.
[20] H. Reichmann,et al. Non-motor dysfunction in Parkinson's disease. , 2007, Parkinsonism & related disorders.
[21] G. Halliday,et al. An inflammatory review of Parkinson’s disease , 2002, Progress in Neurobiology.
[22] P. Silburn,et al. Olfactory Mucosa Is a Potential Source for Autologous Stem Cell Therapy for Parkinson's Disease , 2008, Stem cells.
[23] W. Gibb. Neuropathology of the substantia nigra. , 1991, European neurology.
[24] N. Cairns,et al. An optimistic view for quantifying mRNA in post-mortem human brain. , 2003, Brain research. Molecular brain research.
[25] E. Van Obberghen,et al. Insulin and Insulin-like Growth Factor-I Induce Vascular Endothelial Growth Factor mRNA Expression via Different Signaling Pathways* , 2000, The Journal of Biological Chemistry.
[26] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[27] Peter J. Park,et al. Combining gene expression data from different generations of oligonucleotide arrays , 2004, BMC Bioinformatics.
[28] T. Klockgether,et al. Transcriptional changes in multiple system atrophy and Parkinson's disease putamen , 2006, Experimental Neurology.
[29] N. Cairns,et al. Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. , 2003, Brain research. Molecular brain research.
[30] M. Frosch,et al. Effects of gender on nigral gene expression and parkinson disease , 2007, Neurobiology of Disease.
[31] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[32] Jeremy R. B. Newman,et al. Haplotype analysis of the IGF2‐INS‐TH gene cluster in Parkinson's disease , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[33] N. Hayward,et al. Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses , 2006, Schizophrenia Research.
[34] T. K. Hunt,et al. IGF-I-induced VEGF expression in HUVEC involves phosphorylation and inhibition of poly(ADP-ribose)polymerase. , 2006, Biochemical and biophysical research communications.
[35] C. Comella,et al. Sleep disorders in Parkinson's disease: An overview , 2007, Movement disorders : official journal of the Movement Disorder Society.
[36] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[37] M. Esiri,et al. Alpha‐synuclein pathology in the olfactory pathways of dementia patients , 2007, Journal of anatomy.
[38] W. Silverman,et al. Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures , 1999, Neuroscience.
[39] Stanley J. Watson,et al. Methodological considerations for gene expression profiling of human brain , 2007, Journal of Neuroscience Methods.
[40] E. Cohen,et al. The insulin paradox: aging, proteotoxicity and neurodegeneration , 2008, Nature Reviews Neuroscience.
[41] S. Mandel,et al. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes , 2004, Journal of Neural Transmission.
[42] M. Kameda,et al. Neurorescue effects of VEGF on a rat model of Parkinson's disease , 2005, Brain Research.
[43] H. Braak,et al. Pathology associated with sporadic Parkinson's disease--where does it end? , 2006, Journal of neural transmission. Supplementum.
[44] J. Chilton. Molecular mechanisms of axon guidance. , 2006, Developmental biology.
[45] A J Hughes,et al. Clinicopathological aspects of Parkinson's disease. , 1997, European neurology.
[46] R. Quirion,et al. cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease. , 2003, Pharmacology & therapeutics.
[47] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[48] R. Jensen,et al. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. , 2005, Archives of neurology.
[49] T. Kaysser-Kranich,et al. Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease , 2006, Neurobiology of Disease.
[50] J. Growdon,et al. Molecular markers of early Parkinson's disease based on gene expression in blood , 2007, Proceedings of the National Academy of Sciences.
[51] A. Graybiel,et al. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.
[52] F. Middleton,et al. Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.